Document:

Amendment to Letter of Engagement and Word Authorization

 Exhibit 10.1 
  
 

 
  
 AMENDMENT A TO LETTER OF
ENGAGEMENT 
 AND WORK AUTHORIZATION DATED OCTOBER 1, 2005 
  
 February 2, 2006 
  
 Haris Tajyar 
 Managing Partner 
 Investor Relations International 
 15260 Ventura Blvd., Suite 1060 

Los Angeles, CA 91403 
  
 Dear Haris, 
  
 Given below are the terms for the
continuation of the engagement of Investor Relations International (“IRI”) with Duska Therapeutics, Inc. (the “Company”) for future services commencing on the date of the SEC’s approval of the Company’s soon-to-be filed
Registration Statement. The terms of this letter will amend, as well as add, certain terms of the original agreement between the Company and IRI dated October 1, 2005 (“Original Contract”) as more specifically set forth below. All
terms of the Original Contract that are not amended by this letter will remain in effect. 
  

	1)	Paragraph 3, “Fees,” is hereby amended and restated in its entirety to read: 

  

	 	a.	“A monthly retainer of $10,000.00 payable to IRI for the first twelve months of the engagement period. 

  

	 	b.	“Upon the closing of the private placement the Company is conducting with respect to its common stock, which is expected to close on or around February 10, 2006 (the
“Private Placement”), the Company shall issue to Fountainhead Holdings, Inc. (“Parent”) warrants to purchase (a) 900,000 shares of the Company’s common stock at a price of $0.01 (the “900,000 Warrants”);
(b) 500,000 shares of the Company’s common stock at a price of $0.125 (the “500,000 Warrants”); and (c) 750,000 shares of the Company’s common stock (the “750,000 Warrants”), in each case in accordance with
the forfeiture and vesting provisions set forth in this Paragraph 3. 

  

	 	c.	“In connection with the Private Placement, the Company has agreed to file a Registration Statement (the “Registration Statement”) covering the resale of (1) the
common stock underlying the 900,000 warrants and (2) a minimum of two million shares of the Company’s common stock purchased by the purchasers in the Private Placement at $0.25 per share. 

  

	 	d.	“The 900,000 Warrants shall be subject to forfeiture in the event the Registration Statement is not declared effective by May 15, 2006 since, at this point, there would be
no immediate need for an investor relations program. 

	 	e.	“The 500,000 Warrants shall vest on June 30, 2006 if the following milestones shall have been met on or before June 30, 2006: 

  

	 	1.	IRI will develop the Company’s investor kit, either electronic or paper, and keep it updated. IRI will ensure the investor kit includes the most pertinent and
publicly-available information that an average investor would want to review prior to making an investment decision. 

  

	 	2.	IRI will revamp the Company’s current Website with significant enhancements that will make the site more appealing to potential visitors and with a particular focus on the
investor relations section; 

  

	 	3.	IRI is to provide overall investor relations, some corporate finance and disclosure consulting to the Company and help ensure it remains compliant with all SEC rules and guidelines
as it relates to Regulation Fair Disclosure; 

  

	 	4.	IRI will draft, edit and help distribute all of the Company’s press releases and other forms of shareholder communications to both existing and new potential investors in a
timely manner; 

  

	 	5.	IRI will have increased the Company’s exposure as an investment opportunity to Wall Street. Although this is somewhat an intangible milestone to measure, IRI has agreed to use
the following measuring sticks to determine its success: 

  

	 	a.	Introduction to at least 1,000 new potential retail investors via direct mail campaigns; 

  

	 	b.	Introduction to at least 1,000 new institutional investors, hedge funds, buy- and sell-side analysts and brokerage houses via e-mail using our internal and external databases
(i.e. Bigdough.com, etc.). The $19,000 annual fee per client for this and other investor databases will be incurred by IRI; 

  

	 	c.	Follow-up on any interested investors based on the above marketing efforts in an effort to arrange either one-on-one investor meetings or conference calls with the Company;

  

	 	6.	The above efforts alone should be easily measurable in terms of the expected volatility and liquidity in the Company’s stock price, which hasn’t experienced much, if any
at all for that matter, since its reverse merger. 

  

	 	7.	IRI agrees that at least one article regarding the Company has either been published or is on the verge of publication by a major national news organization. These include, but are
not limited to, print, broadcast, online and/or global wire services. A major national news organization for purposes of this paragraph shall be The Wall Street Journal, New York Times, Business Week, Forbes, CNBC, Dow Jones, Reuters, Bloomberg,
or another similar national news organization agreed to by the parties. 

  

	 	8.	IRI assures that the Company’s investor e-mail list (investors that have opt-in to receive information on the Company) has increased to a minimum of 50 investors from the
current figure of zero. [Note: Most investors these days choose not to be added to a list but rather receive Company information via their brokerage houses (online or via a stockbroker).]  

	 	f.	“The 750,000 Warrants shall vest on the earlier to occur of (i) September 30, 2006 or (ii) the closing bid price of the Company’s common stock being $0.50
if the following milestones shall have been met on or before such date: 

  

	 	1.	IRI will ensure the Company’s revamped website is continuously updated with the latest pertinent investor information; 

  

	 	2.	IRI is to provide overall investor relations, some corporate finance and disclosure consulting to the Company and help ensure it remains compliant with all SEC rules and guidelines
as it relates to Regulation Fair Disclosure; 

  

	 	3.	IRI will draft, edit and help distribute all of the Company’s press releases and other forms of shareholder communications to both existing and new potential investors in a
timely manner; 

  

	 	4.	IRI will have increased the Company’s exposure as an investment opportunity to Wall Street. Although this is somewhat an intangible milestone to measure, IRI has agreed to use
the following measuring sticks to determine its success: 

  

	 	a.	Introduction to at least 5,000 new potential retail investors via direct mail campaigns; 

  

	 	b.	Introduction to at least 3,000 new institutional investors, hedge funds, buy- and sell-side analysts and brokerage houses via e-mail using our internal and external databases
(i.e. Bigdough.com, etc.). The $19,000 annual fee per client for this and other investor databases will be incurred by IRI; 

  

	 	c.	Follow-up on any interested investors based on the above marketing efforts in an effort to arrange either one-on-one investor meetings or conference calls with the Company;

  

	 	d.	At least one major national road show to potential investors IRI has pre-qualified in advance. 

  

	 	5.	The above efforts should be easily measurable in terms of significantly increased volatility and liquidity in the Company’s stock price, which should increase as the Program is
executed; 

  

	 	6.	IRI agrees that it will have generated either at least one major article, national broadcast TV coverage and/or a story reported on a global wire service regarding the Company by
this date that will be printed, broadcasted or available through a global wire service, which shall include The Wall Street Journal, New York Times, Business Week, Forbes, CNBC, Dow Jones, Reuters, Bloomberg, CNN, CNBC, ABC, CBS, NBC, Fox or Fox
News or such other national print, broadcast or global wire service agreed to by the parties.  

  

	 	7.	IRI assures that the Company’s investor e-mail list (investors that have opt-in to receive information on the Company) has increased to a minimum of 100 investors from the
current figure of zero. [Note: Most investors these days choose not to be added to a list but rather receive Company information via their brokerage houses (online or via a stockbroker).] 

	 	g.	“In determining whether the Company’s closing bid price has reached $0.50, appropriate adjustments shall be made to such price for any stock splits, stock dividends or
other similar mechanisms that could restructure the capitalization structure of the Company proportionately among all of its stockholders. 

  

	 	h.	“The Company agrees to file a registration statement covering the resale of the common stock underlying 500,000 Warrants and 750,000 Warrants on behalf of Parent either
(i) on the Registration Statement to be filed pursuant to Paragraph 2 above or (ii) within 30 days of their respective vesting dates. The Company will use its best efforts to have any such registration statement declared effective within
60 days of filing with the SEC. If the common stock underlying the 500,000 Warrants and the 750,000 Warrants are registered on the Registration Statement to be filed pursuant to Paragraph 2, they would be subject to forfeiture in the event the
Registration Statement is not declared effective by May 15, 2006 since, at this point, there would be no immediate need for an investor relations program.” 

  

	2)	Paragraph 4, “Finders Fee,” of the Original Contract shall be hereby deleted in its entirety and shall be amended and restated to read in its entirety,
“[RESERVED]”. 

  

	3)	A new last sentence shall be added to Paragraph 8(d) to read as follows, “IRI further represents and warrants to the Company that it will at all times conduct the services it
provides hereunder in accordance with all state “blue sky” laws, the Securities Act of 1933, as amended, and Rule 10b-5 thereunder, and all other federal and state securities and other laws.” 

  

	4)	Paragraph 6, “Term and Termination of Engagement,” of the Original Contract shall be hereby be amended and restated to read as follows, “The term of the engagement
hereunder is for a period of twelve (12) months. This engagement may be immediately terminated by the Company at any time prior to the expiration of its term, with or without cause; provided, however, that IRI will be entitled to its first
payment of the 900,000 Warrants within 15 days of termination; and provided further that the provisions of this Section and Section 7 hereof shall survive such termination. In addition, following the completion of the Program, management of the
Company and IRI will review the success of the Program in order to determine IRI’s level of involvement going forward.” 

  
 If you agree on the terms listed above, kindly sign the letter in the designated area below and send it back to our corporate office via facsimile. Upon execution by both
parties, this letter will serve as Amendment A to the Original Contract. 
  
 I am
looking forward to working with you in this important area. 
  

					
			
	 /s/ Amir Pelleg
	 	 	 	 /s/ Haris Tajyar

	 Amir Pelleg, Ph.D.
	 	 	 	 Haris Tajyar

	 Chairman and COO
	 	 	 	 Managing Director

	 Duska Therapeutics, Inc.
	 	 	 	 IR InternationalEmployment Agreement between James Woys and Health Net, Inc.

 Exhibit 10.8 
  

					
	

	 	 	 	                    Health Net, Inc.
	 	 	 	                    21650 Oxnard Street
	 	 	 	                    Woodland Hills, CA 91367
	 	 	 	                    818-676-6000
	 	 	 	                    800-291-6911
	 	 	 	                    www.healthnet.com

  
 January 30, 2006 
  
 Mr. James E. Woys 
 President Government & Specialty Services 
 [ADDRESS] 
 [ADDRESS] 
  
 Dear Jim: 
  
 The purpose of this letter agreement (this “Agreement”) is to
memorialize your current employment arrangements with Health Net, Inc. (the “Company”). As you are aware, you and the Company are currently party to a Severance Payment Agreement dated June 1, 1999 and an Agreement dated
January 1, 2001 providing for your consent to certain changes under the Company’s Second Amended and Restated 1991 Stock Option Plan and 1997 Stock Option Plan, as amended (collectively, the “Employment Agreement”). By executing
this Agreement, you agree to the amendment and restatement of your Employment Agreement as set forth herein. 
  
 1. Duties and Salary. 
  
 A. Duties. Your title is President Government & Specialty Services but may be changed at the discretion of the Company to a title that
reflects a similarly senior executive position. You report directly to Jay Gellert, President and Chief Executive Officer of the Company, but your reporting relationship may be changed from time to time at the discretion of the Company. Your duties
and responsibilities are to provide executive leadership and management of the Federal Services business unit, but the Company reserves the right to assign you other duties as needed and to change your duties from time-to-time on reasonable notice,
based on your skills and the needs of the Company. 
  
 B.
Salary. You are paid an annual base salary of $500,000, less applicable withholdings (payable on a bi-weekly basis) (“Base Salary”), which covers all hours worked. Generally, your Base Salary will be reviewed annually, but the
Company reserves the right to change your compensation from time-to-time. Pursuant to the charter of the Compensation Committee (the “Committee”) of the Company’s Board of Directors, any adjustment to your compensation must be made
with the approval of the Committee (or, in the event that you constitute one of the top two (2) highest paid executive officers of the Company, with the ratification of the Company’s Board of Directors). 
  
 C. Disclosure of Personal Compensation Information. As an
“executive officer” of the Company (as such term is defined in the rules and regulations of the Securities and Exchange Commission (“SEC”)), information regarding your employment arrangements with the Company, including, among
other things, the terms of this Agreement and any stock option agreement, restricted stock agreement and/or severance agreement you enter into with the Company from time to time (collectively, “Personal Compensation Information”), may be

  

 - 1 - 

 disclosed in filings with the SEC, the New York Stock Exchange (“NYSE”) and/or other regulatory organizations
upon the occurrence of certain triggering events. Such triggering events include, but are not limited to, the execution of this Agreement and any amendments thereto, changes in your Base Salary, any annual incentive payment (whether in the form of
cash or equity) awarded to you (in the past or after the date hereof), and the establishment of performance goals under the Company’s incentive plans. Your execution of this Agreement will serve as your acknowledgement that your Personal
Compensation Information may be publicly disclosed from time to time in filings with the SEC, NYSE or otherwise as required by applicable law. 
  
 2. Adjustments and Changes in Employment Status. You understand that the Company reserves the right to make personnel decisions regarding your
employment, including but not limited to decisions regarding any promotion, salary adjustment, transfer or disciplinary action, up to and including termination, consistent with the needs of the business or the Company. Generally, your performance
and compensation will be reviewed on an annual basis. 
  
 3.
Protection of Proprietary and Confidential Information. You agree that your employment creates a relationship of confidence and trust with the Company with respect to Proprietary and Confidential Information (as defined below) of the Company
learned by you during your employment. 
  
 A. You agree not to
directly or indirectly use or disclose any of the Proprietary and Confidential Information of the Company or any of its affiliates at any time except in connection with the services you provide to such entities. “Proprietary and Confidential
Information” shall mean trade secrets, confidential knowledge, data or any other proprietary or confidential information of the Company or any of its affiliates, or of any customers, members, employees or directors of any of such entities, but
shall not include any information that (i) was publicly known and made generally available in the public domain prior to the time of disclosure to you by the Company or (ii) becomes publicly known and made generally available after
disclosure to you by the Company. By way of illustration but not limitation, “Proprietary and Confidential Information” includes: (i) trade secrets, documents, memoranda, reports, files, correspondence, lists and other written and
graphic records affecting or relating to any such entity’s business; (ii) confidential marketing information including without limitation marketing strategies, customer and client names and requirements, services, prices, margins and
costs; (iii) confidential financial information; (iv) personnel information (including without limitation employee compensation); and (v) other confidential business information. 
  
 B. You further agree that at all times during your employment and thereafter,
you will keep in confidence and trust all Proprietary and Confidential Information, and that you will not use or disclose any Proprietary and Confidential Information or anything related to such information without the written consent of the
Company, except as may be necessary in the ordinary course of performing your duties to the Company. 
  
 C. All Company property, including, but not limited to, Proprietary and Confidential Information, documents, data, records, apparatus, equipment and other
physical property, whether or not pertaining to Proprietary and Confidential Information, provided to you by the Company or any of its affiliates or produced by you or others in connection with your providing services to the Company or any of its
affiliates shall be and remain the sole property of the Company or its affiliates (as the case may be) and shall be returned promptly to such appropriate entity as and when requested by such entity. You shall return and deliver all such property
upon termination of your employment, and you may not take any such property or any reproduction of such property upon such termination. 
  

 - 2 - 

 D. You recognize that the Company and its affiliates have received and in the future will receive
information from third parties which is private, proprietary or confidential information subject to a duty on such entity’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. You agree that
during your employment, and thereafter, you owe such entities and such third parties a duty to hold all such private, proprietary or confidential information received from third parties in the strictest confidence and not to disclose it, except as
necessary in carrying out your work for such entities consistent with such entities’ agreements with such third parties, and not to use it for the benefit of anyone other than for such entities or such third parties consistent with such
entities’ agreements with such third parties. 
  
 E. Your
obligations under this Section 3 shall continue after the termination of your employment and any breach of this Section 3 shall be a material breach of this Agreement. 
  
 4. Representation and Warranty of Employee. You represent and warrant to the Company that the performance of your
duties, and the entering into of this Agreement, has not violated and will not violate any agreements with or trade secrets of any other person or entity. You further represent and warrant that you do not have any relationship or commitment to any
other person or entity that might be in conflict with your obligations to the Company under this offer, including but not limited to outside employment, sales broker relationships, investments or business activities. You further understand and agree
that while employed by the Company you are expected to refrain from engaging in any outside activities that might be in conflict with the business interests of the Company. In addition, you represent and warrant to the Company that you have not
shared with or disclosed to, and will not share with or disclose to, the Company any proprietary or confidential information of your previous employers or any other third party. 
  
 5. Employee Benefits. 
  
 A. Employee Benefit Programs. You may be eligible for various employee benefit programs if you meet the applicable participation requirements.
These benefit programs include paid time off (“PTO”), holidays, group medical, dental, vision, term life, and short and long term disability insurance and participation in the Company’s 401(k) plan, deferred compensation plan and
tuition reimbursement plan. You will also be eligible to participate in any employee benefit programs added at any future time that are generally applicable to senior executives of the Company and that have been approved by the Committee, provided
that you meet the applicable participation requirements; provided, however, that this provision does not extend to any individually negotiated or tailored benefits, plans or programs covering a particular employee or employees.
Although the Company may sponsor a benefit or plan or program for some employees, it is not required to do so for all employees and may exclude certain employees now or in the future from one or more benefits, plans or programs. The Company or its
subsidiaries or affiliates may modify, terminate or amend any benefit or plan in its discretion, retroactively or prospectively, subject only to applicable law. 
  

B. Required Insurance. You are covered by workers’ compensation insurance and state disability insurance, as required by state law.

  

 - 3 - 

 C. Financial Counseling Allowance. You are reimbursed up to the amount of $5,000 per year for
documented costs incurred for your personal financial counseling services, including tax preparation. 
  
 D. Car Allowance. You are entitled to a car allowance of $1,000 per month. 
  
 E. Incentive Bonus. You are eligible to participate in the Health Net, Inc. Executive Incentive Plan (also known as
the Management Incentive Plan (“MIP”)) in accordance with the terms of the MIP, which provides you with a target opportunity to earn each plan year up to 80% of your Base Salary as additional compensation according to the terms of the
actual MIP documents. The bonus payment will range from 0% to 200% of target depending upon the actual results achieved, and specific, individually tailored measures will be established by the Company that must be achieved by you in order for you to
be eligible to receive bonus payments for a given plan year. It is understood that the Committee and the Company will award bonus amounts, if any, as it deems appropriate consistent with the guidelines of the MIP. You acknowledge that in the event
you are one of the top five (5) highest paid executive officers of the Company for a given calendar year under applicable federal securities laws, your bonus for that year, if any, will be subject to the Company’s Performance Based 162(m)
Plan in lieu of the MIP. 
  
 F. Expenses. Subject to and in
accordance with the Company’s written guidelines and procedures for business and travel expenses, you will receive reimbursement for all business travel and other out-of-pocket expenses reasonably incurred by you in the performance of your
duties pursuant to this Agreement. 
  
 6. Stock Options.
Any stock options or restricted stock granted to you have been or will be granted under the applicable Company Stock Option Plan (the “Stock Option Plan”), and have been or will be subject to the terms of the Company’s form of stock
option agreement or restricted stock agreement, as applicable, as adopted by the Committee. Any future grants of stock options and/or restricted stock to you are at the discretion of the Committee. 
  
 A. Company Stock Ownership Requirement. In accordance with the
Executive Officer Stock Ownership Guidelines adopted by the Board of Directors of the Company (the “Executive Stock Ownership Guidelines”), you are required to own shares of Common Stock of the Company having a value of one times your Base
Salary in effect from time to time pursuant to this Agreement (the “Stock Ownership Requirement”). The number of shares of Common Stock you are required to own will be calculated based on the average NYSE closing price per share of the
Company’s Common Stock (as adjusted for stock splits and similar changes to the Common Stock) for the most recently completed fiscal year of the Company. 
  

Using your current salary of $500,000 and a stock price of $39.3033, which is the average closing price per share of the Company’s Common Stock as of
December 31, 2005, your current stock ownership requirement is 12,721 (“Target Amount”). Any shares of Company Common Stock that you currently own and any shares of restricted stock of the Company that you own and have vested count
toward the Target Amount. Stock options, unvested shares of restricted stock and shares of Common Stock gifted to others do not count toward the Target Amount. Under the Executive Stock Ownership Guidelines, you will have until August 2006 to comply
with the Stock Ownership Requirement. Please keep in mind that the Target Amount is subject to change from time to time based on (1) changes in the average closing sales price of the Company’s Common Stock on an annual basis and
(2) any changes in your Base Salary made pursuant to and in accordance with Section 1A of this Agreement. 
  

 - 4 - 

 The Committee expects that you will make reasonable progress toward your Stock Ownership Requirement. You will be
notified on an annual basis of any changes in your Target Amount. 
  
 (B) Stock Plan Amendments. In accordance with the Agreement dated January 1, 2001 between you and the Company, you have previously consented, pursuant to Section 14 of the Company’s Second Amended and Restated 1991
Stock Option Plan (the “1991 Plan”) and Section 6.2 of the Company’s 1997 Stock Option Plan, as amended (the “1997 Plan”, and together with the 1991 Plan, the “Plans”), that the Plans, as amended by the
amendments to the Accelerated Provisions of the Plans set forth on Exhibit A attached hereto, shall govern and apply to all of your outstanding options under the Plans, regardless of the date such options were granted. To the extent the
option agreements for your outstanding options under the Plans state anything to the contrary, you and the Company have agreed that such option agreement(s) are amended to be consistent with the foregoing sentence. 
  
 7. Term of Employment. Your employment with the Company is
“at-will,” which means that either you or the Company may terminate the employment relationship at any time, with or without advance notice and with or without Cause (as defined below). Upon termination of your employment for any reason,
in addition to any other payments that may be payable to you hereunder, you (or your beneficiaries or estate) will be paid (in each case to the extent not theretofore paid) within thirty (30) days following your date of termination (or such
shorter period that may be required by applicable law): your annual Base Salary through the date of termination, any compensation previously deferred by you (together with any interest and earnings therein), accrued but unused PTO, reimbursable
expenses incurred by you prior to the termination date and any other compensatory plan, arrangement or program payment to which you may be entitled. 
  
 8. Severance Pay. 
  
 A. If your employment is terminated by the Company without Cause (as defined in subsection (C) below) at any time that is not within two
(2) years after a Change in Control (as defined in subsection (D) below) of Health Net, Inc., you will be entitled to receive, provided you sign a Waiver and Release of Claims substantially in the form attached hereto as Exhibit B,
which is incorporated into this Agreement by reference, 
  
 (a) a lump sum cash payment equal to one (1) year of your Base Salary in effect immediately prior to the date of your termination; and 
  
 (b) the continuation of all your medical, health, disability, life and accident insurance as maintained for
your benefit immediately prior to the date of your termination (collectively, “Benefits”) for a period of one (1) year following the effective date of your termination. 
  
 The lump sum payments referred to above will be paid within thirty (30) days following your termination
of employment. 
  
 B. If at any time within two (2) years
after a Change in Control (as defined in subsection (D) below) of Health Net, Inc. your employment is terminated by the Company without Cause or you terminate your employment for Good Reason (as defined in subsection (E) below) (by giving
the Company at least fourteen (14) days prior written notice of the effective date of termination), then you will be entitled to receive, provided you sign a Waiver and Release 
  

 - 5 - 

 of Claims substantially in the form attached hereto as Exhibit B, which is incorporated into this Agreement by
reference, (i) a lump sum payment equal to two (2) years of your Base Salary in effect immediately prior to the date of your termination, and (ii) the continuation of your Benefits for two (2) years following your date of
termination provided, that in the event the Company requests, in writing, prior to such voluntary termination by you for Good Reason that you continue in the employ of the Company for a period of time up to 90 days following such Change in
Control, then you shall forfeit such severance allowance if you voluntarily leave the employ of the Company prior to the expiration of such period of time. In the event that your employment is voluntarily terminated by you at any time (except for
Good Reason within two (2) years after a Change in Control of Health Net, Inc.), then you shall not be eligible to receive any payments set forth in this Section 8). The lump sum payment will be paid within thirty (30) days following
your termination of employment. 
  
 C. You further understand and
acknowledge that the Company will have no obligation to provide the severance benefits called for in this letter if you terminate your employment voluntarily or if you are terminated for cause. For purposes of this letter, a “termination for
cause” is defined as a termination of employment based on the determination by the Company, in its sole discretion, that you engaged in conduct that (1) violates a federal, state or local law, regulation or ordinance that is material to
your performance or to your trustworthiness, (2) evidences dishonesty, gross carelessness or misconduct, negligence or neglect of duty, breach of a fiduciary obligation, or abandonment of the responsibilities of your position, (3) violates
any policy or known business practice of the Company, (4) evidences habitual drunkenness or narcotic drug addiction, (5) results in the knowing unauthorized disclosure of confidential information relating to the business of the Company or
any of its affiliates, (6) amounts to a breach of your obligations hereunder (or under any Company policy) to protect the proprietary and confidential information of the Company or any of its affiliates, or (7) is adverse to the best
business interests of the Company. 
  
 D. For purposes of this
Agreement, “Change in Control” is defined as any of the following which occurs subsequent to the effective date of your employment: 
  
 (i) Any person (as such term is defined under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)),
corporation or other entity (other than Health Net, Inc. or any of its subsidiaries, or any employee benefit plan sponsored by Health Net, Inc. or any of its subsidiaries) is or becomes the beneficial owner (as such term is defined in Rule 13d-3
under the Exchange Act) of securities of Health Net, Inc. representing twenty percent (20%) or more of the combined voting power of the outstanding securities of Health Net, Inc. which ordinarily (and apart from rights accruing under special
circumstances) have the right to vote in the election of directors (calculated as provided in paragraph (d) of such Rule 13d-3 in the case of rights to acquire Health Net, Inc.’s securities) (the “Securities”); 
  
 (ii) As a result of a tender offer, merger, sale of assets or other major
transaction, the persons who are directors of Health Net, Inc. immediately prior to such transaction cease to constitute a majority of the Board of Directors of Health Net, Inc. (or any successor corporations) immediately after such transaction;

  
 (iii) Health Net, Inc. is merged or consolidated with any
other person, firm, corporation or other entity and, as a result, the shareholders of Health Net, Inc., as determined immediately before such transaction, own less than eighty percent (80%) of the outstanding Securities of the surviving or
resulting entity immediately after such transaction: 
  

 - 6 - 

 (iv) A tender offer or exchange offer is made and consummated for the ownership of twenty percent
(20%) or more of the outstanding Securities of Health Net, Inc.; 
  
 (v) Health Net, Inc. transfers substantially all of its assets to another person, firm, corporation or other entity that is not a wholly-owned subsidiary of Health Net, Inc.; or 
  
 (vi) Health Net, Inc. enters into a management agreement with another person, firm, corporation or other entity that is not
a wholly-owned subsidiary of Health Net, Inc. and such management agreement extends hiring and firing authority over you to an individual or organization other than Health Net, Inc. 
  
 E. For purposes of this Agreement, the term “Good Reason” means any of the following which occurs, without your
consent, subsequent to the effective date of a Change in Control as defined above: 
  
 (i) A demotion or a substantial reduction in the scope of your position, duties, responsibilities or status with the Company, or any removal of you from or any failure to reelect you to any of the positions (or
functional equivalent of such positions) referred to in the introductory paragraphs hereof, except in connection with the termination of your employment for Disability (as defined below), normal retirement or Cause or by you voluntarily other than
for Good Reason; 
  
 (ii) A reduction by the Company in your Base
Salary or a material reduction in the benefits or perquisites available to you as in effect immediately prior to any such reduction; 
  
 (iii) A relocation of you to a work location more than fifty (50) miles from your work location immediately prior to such proposed relocation;
provided that such proposed relocation results in a materially greater commute for you based on your residence immediately prior to such relocation; or 
  
 (iv) The failure of the Company to obtain an assumption agreement from any successor contemplated under Section 14 of this Agreement. 
  
 9. Termination by the Company for Cause. The Company may terminate
your employment for Cause at any time with or without advance notice. In the event of such termination, you will not be eligible to receive any of the payments set forth in Section 8(A) or 8(B) above. 
  
 10. Termination due to Death or Disability. In the event that your
employment is terminated at any time due to death or Disability, you (or your beneficiaries or estate) shall be entitled, to (a) continuation of your Benefits for a period of six (6) months from the date of termination and (b) a lump
sum payment equal to one-half (1/2) your Base Salary in effect immediately prior to the date of your termination, to be paid within thirty (30) days following your termination of employment, provided in the event of a termination due to
Disability, you sign the Waiver and Release of Claims which is incorporated into this Agreement by reference as Exhibit B. For purposes of this Agreement, a termination for “Disability” shall mean a termination of your
employment due to your absence from your duties with the Company on a full-time basis for at least 180 consecutive days as a result of your incapacity due to physical or mental illness. 
  

 - 7 - 

 11. Withholding. All payments required to be made by the Company hereunder to you or your estate
or beneficiaries shall be subject to the withholding of such amounts relating to taxes as the Company may reasonably determine should be withheld pursuant to any applicable law or regulation. 
  
 12. Potential Tax Consequences for “Parachute” Payments.

  
 A. Notwithstanding any other provisions of this Agreement, in
the event that (i) any payment or distribution by the Company to or for your benefit (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or any other plan, arrangement or agreement with the Company,
any person whose actions result in a Change in Control or any person affiliated with the Company or such person) (all such payments and distributions, including the severance payments and benefits provided for in Section 8 hereof (the
“Severance Payments”), being hereinafter called (“Total Payments”) would be subject (in whole or part) to the excise tax imposed under Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”), or
any successor provision enacted under the Code or any interest or penalties are incurred by you with respect to such excise tax (such excise tax, together with any such interest and penalties, are hereinafter collectively referred to as the
“Excise Tax”) and (ii) there are any excess parachute payments (within the meaning of Section 280G(b) of the Code or any successor provision enacted under the Code), in the aggregate, in respect of such Total Payments in excess
of $50,000, then the Company shall pay to you an additional cash payment (the “Tax Gross-up”) so that after receipt of such Tax Gross-up, the payment of any additional federal, state and local income taxes on such Tax Gross-up amount and
the payment of any Excise Taxes, you shall receive such net amount of Total Payments equal to the amount that you would have received if no Excise Tax was due; provided, however, that you shall cooperate in good faith with the Company
to minimize the amount of the Excise Tax that may become payable by taking any such action or making any such election as may be reasonably requested by the Company in respect of the Total Payments due to you. 
  
 B. Subject to the provisions of Section 12(C), all determinations
required to be made under this Section 12, including whether and when a Tax Gross-Up is required and the amount of such Tax Gross-Up and the assumptions to be utilized in arriving at such determination, shall be made by the public accounting
firm that, immediately prior to the Change in Control, was the Company’s independent auditor (the “Accounting Firm”) which shall provide detailed supporting calculations both to the Company and you within fifteen (15) business
days of the receipt of notice from you that you have received Total Payments, or such earlier time as is requested by the Company. All fees and expenses of the Accounting Firm shall be borne solely by the Company. Any Tax Gross-Up, as determined
pursuant to this Section 12, shall be paid by the Company to you within five (5) days of the receipt of the Accounting Firm’s determination. If the Accounting Firm determines that no Excise Tax is payable by you, then the Accounting
Firm shall furnish to you a written opinion that failure to report the Excise Tax on your applicable federal income tax return would not result in the imposition of any tax assessment or a negligence or similar penalty. Any determination by the
Accounting Firm shall be binding upon you and the Company. As a result of any uncertainty in the application of Section 4999 of the Code at the time of the determination by the Accounting Firm hereunder, it is possible that Tax Gross-Up which
will not have been made by the Company should have been made (“Underpayment”), consistent with the calculations required to be made hereunder. In the event that the Company exhausts its remedies pursuant to Section 12(C) and you
thereafter are required to make a payment of any Excise Tax, the Accounting Firm shall determine the amount of the Underpayment that has occurred and any such Underpayment shall be promptly paid by the Company to you or for your benefit. 

 

 - 8 - 

 C. You shall notify the Company in writing of any claim by the Internal Revenue Service that, if
successful, would require the payment by the Company of the Tax Gross-Up. Such notification shall be given as soon as practicable but no later than ten (10) business days after you are informed in writing of such claim and shall apprise the
Company of the nature of such claim and the date on which such claim is requested to be paid. You shall not pay such claim prior to the expiration of the thirty (30) day period following the date on which you give such notice to the Company (or
such shorter period ending on the date that any payment of taxes with respect to such claim is due). If the Company notifies you in writing prior to the expiration of such period that it desires to contest such claim, you shall: 
  
 (1) give the Company any information reasonably requested by
the Company relating to such claim, 
  
 (2) take
such action in connection with contesting such claim as the Company shall reasonably request in writing from time to time, including, without limitation, accepting legal representation with respect to such claim by an attorney reasonably selected by
the Company, 
  
 (3) cooperate with the Company
in good faith in order effectively to contest such claim, and 
  
 (4) permit the Company to participate in any proceedings relating to such claim; 
  
 provided, however, that the Company shall bear and pay directly all costs and expenses (including additional interest and penalties) incurred in connection
with such contest and shall indemnify and hold you harmless, on an after-tax basis, for any Excise Tax or income tax (including interest and penalties with respect thereto) imposed as a result of such representation and payment of costs and
expenses. Without limitation on the foregoing provisions of this Section 12(C), the Company shall control all proceedings taken in connection with such contest and, at its sole option, may pursue or forego any and all administrative appeals,
proceedings, hearings and conferences with the taxing authority in respect of such claim and may, at its sole option, either direct you to pay the tax claimed and sue for a refund or contest the claim in any permissible manner, and you agree to
prosecute such contest to a determination before any administrative tribunal, in a court of initial jurisdiction and in one or more appellate courts, as the Company shall determine; provided further, that if the Company directs you to
pay such claim and sue for a refund, the Company shall advance the amount of such payment to you on an interest-free basis and shall indemnify and hold you harmless, on an after-tax basis, from any Excise Tax or income tax (including interest or
penalties with respect thereto) imposed with respect to such advance or with respect to any imputed income with respect to such advance and any and all costs and expenses of any such contest, dispute and/or appeal that you pay directly; and
provided further, that any extension of the statute of limitations relating to payment of taxes for your taxable year with respect to which such contested amount is claimed to be due is limited solely to such contested amount.
Furthermore, the Company’s control of the contest shall be limited to issues with respect to which a Tax Gross-Up would be payable hereunder and you shall be entitled to settle or contest, as the case may be, any other issue raised by the
Internal Revenue Service or any other taxing authority. 
  
 D. If,
after your receipt of an amount advanced by the Company pursuant to Section 12(C), you become entitled to receive, and receive, any refund with respect to such claim, you shall (subject to the Company’s complying with the requirements of
Section 12(C)) 
  

 - 9 - 

 promptly pay to the Company the amount of such refund (together with any interest paid or credited thereon after taxes
applicable thereto). If, after your receipt of an amount advanced by the Company pursuant to Section 12(C), a determination is made that you shall not be entitled to any refund with respect to such claim and the Company does not notify you in
writing of its intent to contest such denial of refund prior to the expiration of thirty (30) days after such determination, then such advance shall be forgiven and shall not be required to be repaid and the amount of such advance shall offset,
to the extent thereof, the amount of Tax Gross-Up required to be paid. 
  
 E. At the time that payments are made under this Section 12, the Company shall provide you with a written statement setting forth the manner in which such payments were calculated and the basis for such calculations including, without
limitation, any opinions or other advice the Company has received from tax counsel, the Auditor or other advisors or consultants (and any such opinions or advice which are in writing shall be attached to the statement). 
  
 13. Restrictive Covenants. 
  
 A. You hereby agree that, during (i) the six (6)-month period following
a termination of your employment with the Company that entitles you to receive severance benefits under this Agreement or a written agreement with or policy of the Company or (ii) the twelve (12)-month period following a termination of your
employment with the Company that does not entitle you to receive such severance benefits (the period referred to in either clause (i) or (ii), the “Restricted Period”), you shall not undertake any employment or activity (including,
but not limited to, consulting services) with a Competitor (as defined below) in any geographic area in which the Company or any of its affiliates operate (the “Market Area”), where the loyal and complete fulfillment of the duties of the
competitive employment or activity would call upon you to reveal, to make judgments on or otherwise use or disclose any confidential business information or trade secrets of the business of the Company or any of its affiliates to which you had
access during your employment with the Company. For purposes of this Section, “Competitor” shall refer to any health maintenance organization or insurance company that provides managed health care or related services similar to those
provided by the Company or any of its affiliates. 
  
 B. In
addition, you agree that, during the applicable Restricted Period following termination of your employment with the Company, you shall not, directly or indirectly, (i) solicit, interfere with, hire, offer to hire or induce any person, who is or
was an employee of the Company or any of its affiliates at the time of such solicitation, interference, hiring, offering to hire or inducement, to discontinue his/her relationship with the Company or any of its affiliates or to accept employment by,
or enter into a business relationship with, you or any other entity or person or (ii) solicit, interfere with or otherwise contact any customer or client of the Company or any of its affiliates. 
  
 C. It is hereby further agreed that if any court of competent jurisdiction
shall determine that the restrictions imposed in this Section 13 are unreasonable (including, but not limited to, the definition of Market Area or Competitor or the time period during which this provision is applicable), the parties hereto
hereby agree to any restrictions that such court would find to be reasonable under the circumstances. 
  
 D. You also acknowledge that the services to be rendered by you to the Company are of a special and unique character, which gives this Agreement a
peculiar value to the Company or any of its affiliates, the loss of which may not be reasonably or adequately 
  

 - 10 - 

 compensated for by damages in an action at law, and that a material breach or threatened breach by you of any of the
provisions contained in this Section 13 will cause the Company or any of its affiliates irreparable injury. You therefore agree that the Company may be entitled, in addition to the remedies set forth above in this Section 13 and any other
right or remedy, to a temporary, preliminary and permanent injunction, without the necessity of proving the inadequacy of monetary damages or the posting of any bond or security, enjoining or restraining you from any such violation or threatened
violations. 
  
 14. Successors; Binding Agreement.

  
 A. This Agreement shall not be terminated by any merger or
consolidation of the Company whereby the Company is or is not the surviving or resulting corporation or as a result of any transfer of all or substantially all of the assets of the Company. In the event of any such merger, consolidation or transfer
of assets, the provisions of this Agreement shall be binding upon the surviving or resulting corporation or the person or entity to which such assets are transferred. 
  
 B. The Company agrees that concurrently with any merger, consolidation or transfer of assets referred to in this
Section 14, it will cause any successor or transferee to unconditionally assume, by written instrument delivered to you (or his beneficiary or estate), all of the obligations of the Company hereunder. Failure of the Company to obtain such
assumption prior to the effectiveness of any such merger, consolidation or transfer of assets shall be a breach of this Agreement and shall entitle you to compensation and other benefits from the Company in the same amount and on the same terms as
you would be entitled hereunder if your employment were terminated without Cause. For purposes of implementing the foregoing, the date on which any such merger, consolidation or transfer becomes effective shall be deemed the date of termination.

  
 C. This Agreement shall inure to the benefit of and be
enforceable by your personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If you shall die while any amounts would be payable to you hereunder had you continued to live, all such
amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to such person or persons appointed in writing by you to receive such amounts or, if no person is so appointed, to your estate. 
  
 15. Severability. If any term of this Agreement is held to be invalid,
void or unenforceable, the remainder of this Agreement shall remain in full force and effect and shall in no way be affected and the parties shall use their best efforts to find an alternative way to achieve the same result. 
  
 16. Integrated Agreement. This Agreement supersedes any prior
agreements, representations or promises of any kind, whether written, oral, express or implied between the parties hereto with respect to the subject matters herein, including, but not limited, to the Employment Agreement. It constitutes the full,
complete and exclusive agreement between you and the Company with respect to the subject matters herein. This Agreement cannot be changed unless in writing, signed by you and an appropriately authorized officer of the Company and approved by the
Board of Directors of the Company (or the Committee, if permitted by the Committee’s charter). 
  
 17. Waiver. No waiver of any default hereunder shall operate as a waiver of any subsequent default. Failure by either party to enforce any of the
terms or conditions of this Agreement, for any length of time or from time to time, shall not be deemed to waive or decrease the rights of such party to insist thereafter upon strict performance by the other party. 
  

 - 11 - 

 18. Notices. All notices and communications required or permitted hereunder shall be in writing
and shall be deemed given (a) if delivered personally, (b) one (1) business day after being sent by Federal Express or a similar commercial overnight service, or (c) three (3) business days after being mailed by registered
or certified mail, return receipt requested, prepaid and addressed to the following addresses, or at such other addresses as the parties may designate by written notice in the manner aforesaid: 
  

			
	If to the Company:	 	Health Net, Inc.
	 	 	Organization Effectiveness Department
	 	 	21650 Oxnard Street, 22nd Floor
	 	 	Woodland Hills, CA 91367
	 	 	Attention: Karin Mayhew
		
	If to the Employee:	 	Mr. James E. Woys
	 	 	[ADDRESS]
	 	 	[ADDRESS]

  
 19. Governing
Law. The interpretation, construction and performance of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware without regard to the principle of conflicts of laws. The
invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provisions of this Agreement, which other provisions shall remain in full force and effect. 
  
 20. Survival and Enforcement. Sections 3, 8, 10, 12 and 13 of this
Agreement and any rights and remedies arising out of this Agreement shall survive and continue in full force and effect in accordance with the respective terms thereof, notwithstanding any termination of this Agreement or your employment. The
parties agree that the Company would be damaged irreparably in the event any provision of Sections 3 or 13 of this Agreement were not performed in accordance with its terms or were otherwise breached and that money damages would be an inadequate
remedy for any such nonperformance or breach. Therefore, the Company or its successors or assigns shall be entitled in addition to other rights and remedies existing in their favor, to an injunction or injunctions to prevent any breach or threatened
breach of any of such provisions and to enforce such provisions specifically (without posting a bond or other security). 
  
 21. Acknowledgement. You acknowledge that you have had the opportunity to discuss the content of this Agreement with and obtain advice from your
attorney, have had sufficient time to and have carefully read and fully understood all of the provisions of this Agreement, and you are knowingly and voluntarily entering into this Agreement. You further acknowledge that you are obligated to become
familiar with and comply at all times with all written policies of the Company. 
  

 - 12 - 

 In order to confirm your agreement with the Company and your acceptance of these terms, please sign one copy of this
letter agreement and return it to me. 
  

	
	 Sincerely,

	
	 /s/ Jay Gellert

	 Jay Gellert

	 President and Chief Executive Officer

  

	cc:	Karin Mayhew 

 Debbie J. Colia/J.E.Woys Personnel File

  
 This will confirm my agreement to the terms
of my employment with the Company as set forth in this letter agreement. 
  

	
	 /s/ James Woys

	 James E. Woys

  

 - 13 - 

 EXHIBIT A 
  
 Amendment to Second Amended and Restated 1991 Stock Option Plan 
  
 The Health Net, Inc. Second Amended and Restated 1991 Stock Option Plan (the “1991 Plan”) is hereby amended to delete paragraph 8
of the 1991 Plan in its entirety and to replace it with the following new paragraph 8: 
  
 “8. ACCELERATION OF OPTIONS AND RESTRICTED SHARES. 
  
 Notwithstanding any contrary waiting period or installment period in any Stock Option Agreement or any Restriction Period in any Restricted Shares Agreement or in the Restated 1991 Plan, each outstanding Option granted under the Restated
1991 Plan shall, except as otherwise provided in the applicable Stock Option Agreement, become exercisable in full for the aggregate number of shares covered thereby, and each Restricted Share, except as otherwise provided in the Restricted Shares
Agreement, shall vest unconditionally, in the event (i) the Company shall consummate (a) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation or pursuant to which shares of Common
Stock are converted into cash, securities or other property, other than a Merger, or (b) any sale, lease, exchange, or other transfer (in one transaction or a series of related transactions) of all, or substantially all, of the assets of the
Company, or (c) the liquidation or dissolution of the Company, or (ii) any person (as such term is defined in Sections 13(d)(3) and 14(d)(2) of the Exchange Act), corporation or other entity (other than the Company or any employee benefit
plan sponsored by the Company or any Subsidiary) (A) shall purchase any Common Stock of the Company (or securities convertible into the Company’s Common Stock) for cash, securities or any other consideration pursuant to a tender offer or
exchange offer, without the prior consent of the Board, and (B) shall become the “beneficial owner” (as such term is defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 20
percent or more of the combined voting power of the then outstanding securities of the Company ordinarily (and apart from rights accruing under special circumstances) having the right to vote in the election of directors (calculated as provided in
paragraph (d) of such Rule 13d-3 in the case of rights to acquire the Company’s securities), or (iii) during any period of two consecutive years, individuals who at the beginning of such period constitute the entire Board shall cease
for any reason to constitute a majority thereof unless the election, or the nomination for election by the Company’s stockholders, of each new director was approved by a vote of at least two-thirds of the directors then still in office who were
directors at the beginning of the period, or (iv) there occurs such other transactions involving a significant issuance of voting stock or change in the composition of the Board that the Board determines to be an accelerating event under this
paragraph 8. Any transaction referred to in the foregoing clause (i) is herein called a Consummated Transaction, any purchase pursuant to a tender offer or exchange offer or otherwise as described in the foregoing clause (ii) is herein
called a Control Purchase, the cessation of individuals constituting a majority of the Board as described in the foregoing clause (iii) is herein called a Board Change and such other transactions as described in the foregoing clause
(iv) is herein called an “Other Accelerating Event”. The Stock Option Agreement and Restricted Shares Agreement evidencing Options or Restricted Shares granted under the Restated 1991 Plan may contain such provisions limiting the
acceleration of the exercisability of Options and the acceleration of the vesting of Restricted Shares as provided in this paragraph 8 as the Committee deems appropriate to ensure that the penalty provisions of Section 4999 of the Code, or any
successor thereto in effect at the time of such acceleration, will not apply to any stock, cash or other property received by the Holder from the Company.” 
  

 - 14 - 

 The 1991 Plan is hereby further amended to delete all references to “Approved Transaction” in
the 1991 Plan and to replace all such references with “Consummated Transaction.” 
  
 Amendment to 1997 Stock Option Plan 
  
 The Health Net, Inc. 1997 Stock Option Plan (the “1997 Plan”) is hereby amended to delete subsection 6.8(b) of the 1997 Plan in its entirety and to replace it with the following new subsection 6.8(b):

  

	“	(b) Definition of Change in Control. A “Change in Control” shall mean: 

  
 (i) Consummated Transaction. Consummation of (a) any consolidation or merger of the Company in which the Company
is not the continuing or surviving corporation or pursuant to which shares of Common Stock are converted into cash, securities or other property, other than a Merger, or (b) any sale, lease, exchange, or other transfer (in one transaction or a
series of related transactions) of all, or substantially all, of the assets of the Company, or (c) the liquidation or dissolution of the Company; 
  
 (ii) Control Purchase. The purchase by any person (as such term is defined in Sections 13(d)(3) and 14(d)(2) of the Exchange Act), corporation or
other entity (other than the Company or any employee benefit plan sponsored by an Employer) of any Common Stock of the Company (or securities convertible into the Company’s Common Stock) for cash, securities or any other consideration pursuant
to a tender offer or exchange offer, without the prior consent of the Board and, after such purchase, such person shall be the “beneficial owner” (as such term is defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of
securities of the Company representing 20 percent or more of the combined voting power of the then outstanding securities of the Company ordinarily (and apart from rights accruing under special circumstances) having the right to vote in the election
of directors (calculated as provided in Section (d) of such Rule 13d-3 in the case of rights to acquire the Company’s securities); 
  
 (iii) Board Change. A change in the composition of the Board during any period of two consecutive years, such that individuals who at the beginning
of such period constitute the entire Board shall cease for any reason to constitute a majority thereof unless the election, or the nomination for election by the Company’s stockholders, of each new director was approved by a vote of at least
two-thirds of the directors then still in office who were directors at the beginning of the period; or 
  
 (iv) Other Transactions. The occurrence of such other transactions involving a significant issuance of voting stock or change in the composition of
the Board that the Board determines to be a Change in Control for purposes of the Plan. 
  
 The Agreement evidencing options or Restricted Stock granted under the Plan may contain provisions limiting the acceleration of the exercisability of options and the acceleration of the vesting of Restricted Stock as
provided in this Section as the Committee deems appropriate to ensure that the penalty provisions of Section 4999 of the Code, or any successor thereto in effect at the time of such acceleration, will not apply to any stock, cash or other
property received by the holder from the Company.” 
  

 - 15 - 

 EXHIBIT B 
  
 WAIVER AND RELEASE OF CLAIMS 
  
 This WAIVER AND RELEASE OF CLAIMS (this “Release”) is made and entered into by and between Health Net, Inc. and its affiliates and subsidiaries
(hereinafter referred to as the “Company”) and James E. Woys (hereinafter referred to as the “Employee”). 
  
 WHEREAS, the Company and Employee are parties to an Employment Letter Agreement dated as of August 5, 2005 (the “Employment Letter
Agreement”) and are entering into this Release as a condition to Employee’s receipt of a severance payment thereunder (capitalized terms used but not defined herein shall have the meanings set forth in the Employment Letter Agreement).

  
 NOW, THEREFORE, the Company and Employee agree as follows:

  

	1.	Employee’s employment with the Company will terminate on [TERM DATE ] (the “Termination Date”). Upon termination of employment, Employee will not represent to
anyone that he is an employee of the Company and will not say or do anything purporting to bind the Company. Upon Employee’s termination of employment, Employee shall be deemed to have resigned from all other positions with the Company, if any,
held by Employee. 

  

	2.	Employee’s termination of employment with the Company shall be considered a [DESCRIBE TYPE OF TERMINATION] under the Employment Letter Agreement, and Employee is
therefore eligible to receive [DESCRIBE PAYMENTS AND OTHER BENEFITS TO BE RECEIVED]. 

  

	3.	Employee acknowledges that all unused accrued vacation and unused personal absence time will be paid in Employee’s final regular paycheck in keeping with the Company’s
policy and practice or such shorter time as may be required by applicable law. Employee further acknowledges that no further vacation/paid-time-off benefits will accrue after the Termination Date. 

  

	4.	Employee’s participation in all Company employee benefit plans as an active employee shall cease on the Termination Date, and Employee shall not be eligible to make
contributions to or to receive allocations under the Health Net, Inc. 401(k) Associate Savings Plan or to make any deferrals pursuant to any deferred compensation plan of the Company after the Termination Date. 

  

	5.	In partial consideration of the Company providing Employee the payments and benefits set forth above and as a condition to receive such payments and benefits, Employee freely and
voluntarily enters into this Release and by signing this Release Employee, on his/her own behalf and on behalf of his or her heirs, beneficiaries, successors, representatives, trustees, administrators and assigns, hereby waives and releases the
Company, and each of its past, present and future officers, directors, shareholders, employees, consultants, accountants, attorneys, agents, managers, insurers, sureties, parent and sister corporations, divisions, subsidiary corporations and
entities, partners, joint venturers, affiliates, beneficiaries, successors, representatives and assigns (collectively, the “Released Parties”), from any and all claims, demands, damages, 

  

 - 16 - 

 debts, liabilities, controversies, obligations, actions or causes of action of any nature whatsoever,
whether based on tort, statute, contract, (specifically including, but not limited to, claims arising out of or related to the Employment Letter Agreement) indemnity, rescission or any other theory of recovery, including but not limited to claims
arising under federal, state or local laws prohibiting discrimination in employment, including Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1866, as amended, claims of disability discrimination under the Americans
with Disabilities Act, as amended, the Age Discrimination in Employment Act, as amended (“ADEA”), the Worker Adjustment and Retraining Notification Act, as amended (“WARN”), the Fair Labor Standards Act, as amended,
the Family and Medical Leave Act, as amended, the California Fair Employment and Housing Act, as amended, the California Family Rights Act, California Labor Code Section 1400 et seq. or claims growing out of any legal restrictions on the
Company’s right to terminate its employees and whether for compensatory, punitive, equitable or other relief, whether known, unknown, suspected or unsuspected, against the Released Parties, including without limitation claims
which may have arisen or may in the future arise in connection with any event which occurred on or before the date of Employee’s execution of this Release. The provisions in this paragraph do not extend to any rights Employee may have to
enforce the terms of this Agreement and are not intended to prohibit Employee from filing a claim for unemployment insurance. 
  

	6.	Employee expressly waives any right or claim of right to assert hereafter that any claim, demand, obligation and/or cause of action has, through ignorance, oversight or error, been
omitted from the terms of this Release. Employee makes this waiver with full knowledge of his/her rights and with specific intent to release both his/her known and unknown claims, and therefore specifically waives the provisions of Section 1542
of the Civil Code of California or other similar provisions of any other applicable law, which reads as follows: 

  
 “A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the
release, which if known by him must have materially affected his settlement with the debtor.” 
  
 Employee understands and acknowledges the significance and consequence of this Release and of such specific waiver of Section 1542, and expressly
agrees that this Agreement shall be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected claims, demands, obligations and causes of action herein above
specified. 
  

	7.	Employee shall not initiate or cause to be initiated against the Company any compliance review, suit, action, investigation or proceeding of any kind, or voluntarily participate in
same, individually or as a representative, witness or member of a class, under contract, law or regulation, federal, state or local, pertaining to any matter related to his employment with the Company, unless Employee first cooperates in making his
allegations known to the Company for the Company to take corrective action at a time and place designated by the Company. In addition, Employee shall, without further compensation, cooperate with and assist the Company in the investigation of,
preparation for or defense of any actual or threatened third party claim, investigation or proceeding involving the Company or its predecessors or affiliates and arising from or relating to, in whole or in part, Employee’s employment with the
Company or its predecessors or 

  

 - 17 - 

 affiliates for which the Company requests Employee’s assistance, which cooperation and assistance
shall include, but not be limited to, providing testimony and assisting in information and document gathering efforts. In this connection, it is agreed that the Company will use its reasonable best efforts to assure that any request for such
cooperation will not unduly interfere with Employee’s other material business and personal obligations and commitments. 
  

	8.	Employee agrees he will return to the Company immediately upon termination any building keys, security passes or other access or identification cards and any Company property that
was in his or her possession, including but not limited to any documents, credit cards, computer equipment, mobile phones or data files. Employee agrees to clear all expense accounts and pay all amounts owed on any corporate credit cards which the
Company previously issued to Employee, subject to the Company’s obligation to reimburse Employee for any properly reimbursable business expenses in accordance with the Company’s expense policies and procedures then in effect.

  

	9.	Employee shall not, without the Company’s written consent by an authorized representative, at any time prior or subsequent to the execution of this Release, disclose, use,
remove or copy any confidential, trade secret or proprietary information he acquired during the course of his employment by the Company, including without limitation, any technical, actuarial, economic, financial, procurement, provider, customer,
underwriting, contractual, managerial, marketing or other information of any type that has economic value in the business in which the Company is engaged, but not including any previously published information or other information generally in the
public domain. 

  

	10.	In addition to any other part or term of this Release or the Employment Letter Agreement, Employee agrees that he will not, (a) for a period of one (1) year from the date
of this Agreement, irrespective of the reason for the termination, either directly or indirectly, on his own behalf or on behalf of any other person: (1) make known to any person, firm, corporation or other entity of any type, the names and
addresses of any of the Company’s customers, enrollees or providers or any other information pertaining to them; or (2) disrupt, solicit or influence or attempt to solicit, disrupt or influence any of the Company’s customers,
providers, vendors, agents or independent contractors with whom the Employee became acquainted during the course of employment or service for the purpose of terminating such a person’s or entity’s relationship with the Company or causing
such a person or entity to associate with a competitor of the Company, and (b) undertake any employment or activity prohibited by the Employment Letter Agreement for the time periods set forth therein. The prohibitions of this paragraph are not
intended to deny employment opportunities within the Employee’s field of employment but are limited only to those prohibitions necessary to protect the Company from unfair competition. 

  

	11.	Employee acknowledges that the Company is not entering into this Release because it believes that Employee has any cognizable legal claim against the Release Parties. If Employee
elects not to sign this Release, the fact that the Release was offered will not be understood as an indication that the Released Parties believed Employee was treated unlawfully in any respect. 

  

	12.	If any part or term of this Release is held invalid or unenforceable, such invalidity or unenforceability shall not affect in any way the validity or enforceability of any other
part or term of this Release. In addition, if any court of competent jurisdiction construes the 

  

 - 18 - 

 covenants contained in Section 10 hereof, or any part thereof, to be unenforceable in any respect,
the court may reduce the duration or scope to the extent necessary so that the provision is enforceable, and the provision, as reduced, shall then be enforceable. 
  

	13.	Employee agrees and acknowledges that this Release recites all payments and benefits Employee is entitled to receive hereunder and under the Employment Agreement, and that no other
payments or benefits will be asserted or requested by Employee. 

  

	14.	Employee enters into this Release freely, without coercion, and based on the Employee’s own judgment and not in reliance upon any representation or promise made by the other
party, other than those contained herein. There may be no modification of the terms of this Release except in writing signed by the parties hereto including an appropriately authorized Officer of the Company. 

  

	15.	This Release constitutes the full, complete and exclusive agreement between you and the Company with respect to the subject matters herein and supersedes any prior agreements,
representations or promises of any kind, whether written, oral, express or implied, with respect to the subject matters herein. 

  

	16.	This Release shall be construed and governed by the laws of the State of Delaware. 

  
 EMPLOYEE ACKNOWLEDGES BY SIGNING BELOW that (i) Employee has not relied upon any representations, written or oral, not
set forth in this Release; (ii) at the time Employee was given this Release Employee was informed in writing by the Company that (a) Employee had at least 21 days in which to consider whether Employee would sign the Release and
(b) Employee should consult with an attorney before signing the Release; and (iii) Employee had an opportunity to consult with an attorney and either had such consultations or has freely decided to sign this Release without consulting an
attorney. 
  
 Employee further acknowledges that he may revoke
acceptance of this Release by delivering a letter of revocation within seven (7) days after the later of the dates set forth below addressed to: Health Net, Inc., Corporate Legal Department, 21650 Oxnard Street, Woodland Hills, California
91367, Attention: General Counsel. 
  
 Finally, Employee
acknowledges that he understands that this Release will not become effective until the eighth (8th) day following his signing this Release and that if Employee does not revoke his acceptance of the terms of this Release within the seven
(7) day period following the date on which Employee signs this Release as set forth above, this Release will be binding and enforceable. 
  
 IN WITNESS WHEREOF, the parties hereto have executed this Release as of the dates set forth below. 
  

							
	Employee	 	Health Net, Inc.
				
	By:	 	 [EXHIBIT COPY]

	 	By:	 	 [EXHIBIT COPY]

	Name:	 	 	 	Name:	 	 
	Title:	 	 	 	Title:	 	 
	Dated:	 	 [TO BE INSERTED]

	 	Dated:	 	 [TO BE INSERTED]

  

 - 19 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]